The p53-p300 and PML-SMAR1 cross-talk leads to the activation of the transcriptional functions of p53, resulting in the transactivation of apoptotic factors such as PUMA, NOXA and BAX and the chemosensitisation of cancer-resistant cells [63]. The gene discussed is TP53; the disease is cancer.